These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38070782)

  • 1. Infliximab aggregates produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response.
    Nabhan M; Meunier S; Le-Minh V; Robin B; de Bourayne M; Smadja C; Maillère B; Pallardy M; Turbica I
    Eur J Pharm Sci; 2024 Jan; 192():106670. PubMed ID: 38070782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FcγRIIa-Syk Axis Controls Human Dendritic Cell Activation and T Cell Response Induced by Infliximab Aggregates.
    Nabhan M; Legrand FX; Le-Minh V; Robin B; Bechara R; Huang N; Smadja C; Pallardy M; Turbica I;
    J Immunol; 2020 Nov; 205(9):2351-2361. PubMed ID: 32989091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of
    Morgan H; Tseng SY; Gallais Y; Leineweber M; Buchmann P; Riccardi S; Nabhan M; Lo J; Gani Z; Szely N; Zhu CS; Yang M; Kiessling A; Vohr HW; Pallardy M; Aswad F; Turbica I
    Front Immunol; 2019; 10():601. PubMed ID: 31001248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab Selectively Modulates the Circulating Blood Monocyte Repertoire in Crohn's Disease.
    Slevin SM; Dennedy MC; Connaughton EP; Ribeiro A; Ceredig R; Griffin MD; Egan LJ
    Inflamm Bowel Dis; 2016 Dec; 22(12):2863-2878. PubMed ID: 27824651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.
    Hamze M; Meunier S; Karle A; Gdoura A; Goudet A; Szely N; Pallardy M; Carbonnel F; Spindeldreher S; Mariette X; Miceli-Richard C; Maillère B
    Front Immunol; 2017; 8():500. PubMed ID: 28529511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab regulates monocytes and regulatory T cells in Kawasaki disease.
    Koizumi K; Hoshiai M; Katsumata N; Toda T; Kise H; Hasebe Y; Kono Y; Sunaga Y; Yoshizawa M; Watanabe A; Kagami K; Abe M; Sugita K
    Pediatr Int; 2018 Sep; 60(9):796-802. PubMed ID: 29543362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10-Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed Patients.
    Vultaggio A; Nencini F; Pratesi S; Cammelli D; Totaro M; Romagnani S; Maggi E; Matucci A;
    J Immunol; 2017 Aug; 199(4):1283-1289. PubMed ID: 28716826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization.
    Gallais Y; Szely N; Legrand FX; Leroy A; Pallardy M; Turbica I
    Immunol Cell Biol; 2017 Mar; 95(3):306-315. PubMed ID: 27713394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
    Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
    Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
    Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
    Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response.
    Talotta R; Berzi A; Atzeni F; Batticciotto A; Clerici M; Sarzi-Puttini P; Trabattoni D
    J Clin Immunol; 2015 Aug; 35(6):550-7. PubMed ID: 26271387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential influences of Fc gamma receptor blocking on the effects of certolizumab pegol and infliximab on human monocytes.
    Hoshiyama T; Matsueda Y; Tono T; Arinuma Y; Nagai T; Hirohata S
    Mod Rheumatol; 2018 May; 28(3):506-512. PubMed ID: 28805137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells.
    Sánchez-Torres C; García-Romo GS; Cornejo-Cortés MA; Rivas-Carvalho A; Sánchez-Schmitz G
    Int Immunol; 2001 Dec; 13(12):1571-81. PubMed ID: 11717198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.
    Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A
    Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization.
    Assas MB; Levison SE; Little M; England H; Battrick L; Bagnall J; McLaughlin JT; Paszek P; Else KJ; Pennock JL
    Clin Exp Immunol; 2017 Feb; 187(2):225-233. PubMed ID: 27669117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
    Arimoto-Miyamoto K; Kadowaki N; Kitawaki T; Iwata S; Morimoto C; Uchiyama T
    Immunology; 2010 May; 130(1):137-49. PubMed ID: 20201989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.
    Vultaggio A; Petroni G; Pratesi S; Nencini F; Cammelli D; Milla M; Prignano F; Annese V; Romagnani S; Maggi E; Matucci A;
    Clin Exp Immunol; 2016 Dec; 186(3):364-372. PubMed ID: 27569750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.
    Li Z; Vermeire S; Bullens D; Ferrante M; Van Steen K; Noman M; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
    López-Bravo M; Minguito de la Escalera M; Domínguez PM; González-Cintado L; del Fresno C; Martín P; Martínez del Hoyo G; Ardavín C
    J Allergy Clin Immunol; 2013 Dec; 132(6):1409-19. PubMed ID: 24139608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.